General Information of the Compound
| Compound ID |
CP0521356
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,2R)-N-{1-Benzyl-2-hydroxy-3-(S)-[2-(1-benzylpiperidin-4-yl)ethylamino]-propyl}-5-nitro-N'-[(R)-1-phenylethyl]isophthalamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C40H47N5O5
|
||||||||||||||||||
| Molecular Weight |
677.846
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H](NC(=O)c1cc(cc(c1)[N+]([O-])=O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCCC1CCN(Cc2ccccc2)CC1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H47N5O5/c1-29(33-15-9-4-10-16-33)42-39(47)34-24-35(26-36(25-34)45(49)50)40(48)43-37(23-31-11-5-2-6-12-31)38(46)27-41-20-17-30-18-21-44(22-19-30)28-32-13-7-3-8-14-32/h2-16,24-26,29-30,37-38,41,46H,17-23,27-28H2,1H3,(H,42,47)(H,43,48)/t29-,37+,38-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OWWDZRJCQISTSQ-NOWQQFBNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound